Between the Biotech Waves
Nessan Bermingham PhD
Outreach Signals
Publishing Details
About This Podcast
Podcasting 2.0 Features
Explore Statistics
Recent Episodes
S2E7 S2 E7: A Between the Biotech Waves Conversation with Bobby Gaspar
Today’s episode features a remarkable leader in the field of gene therapy, Dr. Bobby Gaspar. With over 25 years of experience as a physician and scientist, Bobby has played a pivotal role in…
S2E6 S2 E6: A Between the Biotech Waves Conversation with Steve Paul
I am thrilled to welcome Steve Paul to Between the Biotech Waves.With nearly 50 years of experience as a physician-scientist, Steve has made significant contributions to the fields of neuroscience,…
S2E5 S2 E5: A Between the Biotech Waves Conversation with Kent Rogers
Today, I are excited to welcome Kent Rogers, the Chief Executive Officer of EveryONE Medicines. Kent brings a wealth of experience to his new role, having held executive leadership positions at…
Between the Biotech Waves - Sound Bite - Bill Hicks Co-Chair Life Sciences Practice Mintz
Sound Bite with Bill Hicks looking at the market and financing in real time.
Between the Biotech Waves - Sound Bite - Paul Matteis Equity Analyst Stifel
Welcome to a Between the Biotech Waves sound bite, a short podcast to provide insight into the rapidly changing biotech environment - I am pleased to welcome Paul Matteis Managing Director, Head of…
S2E4 S2 E4: A Between the Biotech Waves Conversation with Dan Lynch
In this episode, I am thrilled to welcome Dan Lynch, an Executive Venture Partner at Google Ventures and a seasoned leader in the biotechnology sector.Since joining GV in 2021, Dan has partnered with…
S2E3 S2 E3: A Between The Biotech Waves Conversation with Stan Crooke, Ionis & N-Lorem Founder
In today's episode, I am honored to welcome Stanley Crooke, the founder and CEO of Ionis Pharmaceuticals the first and leading antisense oligonucleotide biotech and founder, CEO and Chair of N-Lorem,…
S2E2 S2 E2: A Between the Biotech Waves Conversation with Peter Barrett
Welcome to ‘Between the Biotech Waves,’ the podcast where we navigate the dynamic world of biotechnology and explore the minds driving its innovation. I’m your host, Nessan Bermingham, and today, we…
S2E1 S2 Episode 1: A conversation with Matt Porteus
Now that JPM '25 is behind us, where the weather was great but the mood was somber, back to podcasting!Welcome back to 'Between the Biotech Waves,' the podcast where we explore the frontiers of…
S1E35 Episode 35: A Between the Biotech Waves Conversation with Mike Curtis, President & CEO of eGenesis
Welcome back to Between the Biotech Waves. I am sorry for the lack of episodes over the past few months, unfortunately life threw me a curve ball that I have been taking care of but now back and…
S1E33 Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics
Today I am talking to Eliot Forster xCEO of F-star Therapeutics.Eliot was at helm of the company as they reversed merged into Springbank Pharmaceuticals & through the recently announced…
S1E32 Episode 32: The Triplet Therapeutics story, from concept to birth, life & death.
Today we have an unusual (& long) podcast where we talk to key members of the Triplet Therapeutics management team. Triplet was founded to develop antisense oligonucleotides targeting the DNA…
S1E30 Episode 30: A Between the Biotech Waves conversation with Barry Greene, CEO of Sage Therapeutics
Today we are talking to Barry Greene, CEO of Sage Therapeutics. Barry has had an amazing career spanning over 30 years in the biotech industry. Prior to Sage Barry was President of Alnylam…
S1E31 Episode 31: A Between the Biotech Waves Conversation with Tim Yu
Today we are talking to Tim Yu. Tim is attending physician at the division of genetics and genomics at Boston Children’s Hospital and assoc prof of Pediatrics at Harvard Medical School. The scope of…
S1E29 Episode 29: A Between the Biotech Waves conversation with Joel Marcus, Founder & Exec Chair of Alexandria Real Estate
Today we are talking to Joel Marcus. He has shaped the life sciences industry through ARE from the buildings we use to venture and fund investing. His impact can be directly seen in major cities…
S1E28 Episode 28 A Between the Biotech Waves Conversation with Rachel Meyers
Today we are talking to Rachel Meyers. Rachel was most recently the CSO of Faze Medicines a company she launched with TRV to focus on the regulation of biomolecular condensates to treat disease.…
S1E27 Episode 27 A Between the Biotech Waves Conversation with Aoife Brennan, CEO of Synlogic
Today we are talking to Aofie Brennan, president and CEO of Synlogic. Aoife was trained as a doctor at Trinity College Dublin following which she moved to the US. After completing her postdoctoral…
S1E26 Episode 26: A Between the Biotech Waves conversation with Drew Weissman
Today we are talking to Drew Weissman. Drew is the Roberts Family Professor in Vaccine Research at Perelman School of Medicine and Director of the Penn Institute for RNA Innovation at the University…
S1E25 Episode 25: A Between the Biotech Waves conversation with Rodolphe Barrangou, the Todd R Klaenhammer Distinguished Professor at NC State University.
Today we are talking to Rodolphe Barrangou. Rodolphe is the Todd R Klaenhammer Distinguished Professor at NC State University. He is a scientist entrepreneur who has co-founded a multitude of biotech…
S1E24 Episode 24: A Between the Biotech Waves conversation with John Hoffman, managing director & head of healthcare equity capital markets at Credit Suisse
I am delighted to welcome back John Hoffman to Between the Biotech Waves. John is managing director & head of healthcare equity capital markets at Credit Suisse. In mid 2022 John joined the…
Frequently Asked Questions
Between the Biotech Waves has published 43 episodes since May 2022, covering topics in Business, Investing.
Between the Biotech Waves is currently dormant with new episodes weekly. Average episode length is 56m.
